Infection Caused By Molluscum Contagiosum — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infection caused by molluscum contagiosum. 4 active patents protecting 1 drugs from 1+ originators. First major cliff: 2035. Daily refresh.

1
Approved drugs
4
Active US patents
68/100
Avg vulnerability
—
Annual revenue covered

Originators in Infection Caused By Molluscum Contagiosum

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Verrica Pharms 4 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infection caused by molluscum contagiosum. Each bar = one year. Y-axis scaled to peak year (2 patents).

1
35
2
38
1
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Ycanth
CANTHARIDIN
 Verrica Pharms 4 68 — 2035-05-28

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12233042 Ycanth method of use 75 2038-08-22
11052064 Ycanth method of use 70 2035-05-28
11147790 Ycanth method of use 70 2038-08-22
12290651 Ycanth formulation 55 2041-02-19

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
12290651 Ycanth formulation 55 2041-02-19
11147790 Ycanth method of use 70 2038-08-22
11052064 Ycanth method of use 70 2035-05-28
12233042 Ycanth method of use 75 2038-08-22

Related